Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

1H NMR toxicometabolomics following cisplatin-induced nephrotoxicity in male rats.

Ryu SH, Lee JD, Kim JW, Kim S, Kim S, Kim KB.

J Toxicol Sci. 2019;44(1):57-71. doi: 10.2131/jts.44.57.

2.

Serum and urine toxicometabolomics following gentamicin-induced nephrotoxicity in male Sprague-Dawley rats.

Ryu SH, Kim JW, Yoon D, Kim S, Kim KB.

J Toxicol Environ Health A. 2018;81(11):408-420. doi: 10.1080/15287394.2018.1451180. Epub 2018 Apr 2.

PMID:
29608440
3.

Toxicometabolomics approach to urinary biomarkers for mercuric chloride (HgCl₂)-induced nephrotoxicity using proton nuclear magnetic resonance (¹H NMR) in rats.

Kim KB, Um SY, Chung MW, Jung SC, Oh JS, Kim SH, Na HS, Lee BM, Choi KH.

Toxicol Appl Pharmacol. 2010 Dec 1;249(2):114-26. doi: 10.1016/j.taap.2010.08.017. Epub 2010 Sep 9.

PMID:
20804780
4.

Urinary metabolic profiling of cisplatin nephrotoxicity and nephroprotective effects of Orthosiphon stamineus leaves elucidated by 1H NMR spectroscopy.

Pariyani R, Ismail IS, Azam A, Khatib A, Abas F, Shaari K, Hamza H.

J Pharm Biomed Anal. 2017 Feb 20;135:20-30. doi: 10.1016/j.jpba.2016.12.010. Epub 2016 Dec 8.

PMID:
27987392
5.

Potential urinary biomarkers of nephrotoxicity in cyclophosphamide-treated rats investigated by NMR-based metabolic profiling.

Lim SR, Hyun SH, Lee SG, Kim JY, Kim SH, Park SJ, Moon KS, Sul D, Kim DH, Choi HK.

J Biochem Mol Toxicol. 2017 Mar;31(3). doi: 10.1002/jbt.21871. Epub 2016 Nov 21.

PMID:
27870266
6.

Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans.

Kim JW, Ryu SH, Kim S, Lee HW, Lim MS, Seong SJ, Kim S, Yoon YR, Kim KB.

Anal Chem. 2013 Dec 3;85(23):11326-34. doi: 10.1021/ac402390q. Epub 2013 Nov 14.

PMID:
24127682
7.

Effect of glycine on cisplatin nephrotoxicity and heat-shock protein 70 expression in the rat kidney.

Musio F, Carome MA, Bohen EM, Sabnis S, Yuan CM.

Ren Fail. 1997 Jan;19(1):33-46.

PMID:
9044450
8.

Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.

Mohan IK, Khan M, Shobha JC, Naidu MU, Prayag A, Kuppusamy P, Kutala VK.

Cancer Chemother Pharmacol. 2006 Dec;58(6):802-8. Epub 2006 Mar 22.

PMID:
16552571
9.

Resveratrol influences platinum pharmacokinetics: A novel mechanism in protection against cisplatin-induced nephrotoxicity.

Darwish MA, Abo-Youssef AM, Khalaf MM, Abo-Saif AA, Saleh IG, Abdelghany TM.

Toxicol Lett. 2018 Jun 15;290:73-82. doi: 10.1016/j.toxlet.2018.03.023. Epub 2018 Mar 21.

PMID:
29574132
10.

The effect of sildenafil on cisplatin nephrotoxicity in rats.

Ali BH, Abdelrahman AM, Al-Salam S, Sudhadevi M, AlMahruqi AS, Al-Husseni IS, Beegam S, Dhanasekaran S, Nemmar A, Al-Moundhri M.

Basic Clin Pharmacol Toxicol. 2011 Oct;109(4):300-8. doi: 10.1111/j.1742-7843.2011.00724.x. Epub 2011 Jun 22.

11.

Metabolomics approach to risk assessment: methoxyclor exposure in rats.

Kim KB, Kim SH, Um SY, Chung MW, Oh JS, Jung SC, Kim TS, Moon HJ, Han SY, Oh HY, Lee BM, Choi KH.

J Toxicol Environ Health A. 2009;72(21-22):1352-68. doi: 10.1080/15287390903212550.

PMID:
20077207
12.

Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.

Bulacio RP, Torres AM.

Arch Toxicol. 2013 Nov;87(11):1953-1962. doi: 10.1007/s00204-013-1062-0. Epub 2013 May 7.

PMID:
23649842
13.

Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.

Cox IJ, Aliev AE, Crossey MM, Dawood M, Al-Mahtab M, Akbar SM, Rahman S, Riva A, Williams R, Taylor-Robinson SD.

World J Gastroenterol. 2016 Apr 28;22(16):4191-200. doi: 10.3748/wjg.v22.i16.4191.

14.

Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats.

Trujillo J, Molina-Jijón E, Medina-Campos ON, Rodríguez-Muñoz R, Reyes JL, Loredo ML, Tapia E, Sánchez-Lozada LG, Barrera-Oviedo D, Pedraza-Chaverri J.

Toxicol Mech Methods. 2014 Oct;24(7):520-8. doi: 10.3109/15376516.2014.948248. Epub 2014 Aug 11.

PMID:
25052570
15.

Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a major constituent of the Chinese herb Ligusticum wallichi.

Ali BH, Al-Moundhri M, Eldin MT, Nemmar A, Al-Siyabi S, Annamalai K.

Exp Biol Med (Maywood). 2008 Jul;233(7):891-6. doi: 10.3181/0711-RM-315. Epub 2008 Apr 29.

PMID:
18445776
16.

Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model.

Kim KB, Yang JY, Kwack SJ, Park KL, Kim HS, Ryu DH, Kim YJ, Hwang GS, Lee BM.

J Toxicol Environ Health A. 2010;73(21-22):1420-30. doi: 10.1080/15287394.2010.511545.

PMID:
20954069
17.

Evaluation of cadmium-induced nephrotoxicity using urinary metabolomic profiles in sprague-dawley male rats.

Lee YK, Park EY, Kim S, Son JY, Kim TH, Kang WG, Jeong TC, Kim KB, Kwack SJ, Lee J, Kim S, Lee BM, Kim HS.

J Toxicol Environ Health A. 2014;77(22-24):1384-98. doi: 10.1080/15287394.2014.951755.

PMID:
25343288
19.

Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.

Atasoyu EM, Yildiz S, Bilgi O, Cermik H, Evrenkaya R, Aktas S, Gültepe M, Kandemir EG.

Arch Toxicol. 2005 May;79(5):289-93. Epub 2004 Nov 9.

PMID:
15902426
20.

(1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model.

Niu QY, Li ZY, Du GH, Qin XM.

J Pharm Biomed Anal. 2016 Jan 25;118:338-348. doi: 10.1016/j.jpba.2015.10.026. Epub 2015 Oct 30.

PMID:
26595282

Supplemental Content

Support Center